Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial (BOOST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01614015
Recruitment Status : Completed
First Posted : June 7, 2012
Last Update Posted : October 19, 2016
Information provided by (Responsible Party):
Oregon Research Institute

Brief Summary:
The proposed effectiveness study examines differences in treatment outcomes of an observation-based supervision (BOOST) versus supervision as usual (SAU). The study will be implemented within 16 teams delivering FFT services at 11 sites in the California Institute of Mental Health (CIMH) system. The 16 FFT therapist teams will be randomly assigned either to BOOST or SAU. Each team will have 3 therapists who will treat 6 families for a total of 18 families per team. Thus, each condition will include 24 therapists who will treat 144 families. The project will be implemented in four staggered waves to establish a more even rate of data collection and treatment implementation to enhance the feasibility of the study by keeping staffing and project costs more constant across the 5-year project. Each wave will involve 4 FFT teams, 2 receiving BOOST and 2 receiving SAU. Teams will be randomized to supervision conditions. Outcome assessments of parents and adolescents will be conducted at baseline and at 4 months and 16 months after treatment initiation.

Condition or disease Intervention/treatment Phase
Delinquency Substance Abuse Self Destructive Behavior Behavioral: Supervision Behavioral: Observational Supervision Phase 2

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 328 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial
Study Start Date : September 2010
Actual Primary Completion Date : June 2016
Actual Study Completion Date : June 2016

Arm Intervention/treatment
Experimental: Supervision as Usual
Supervision as Usual
Behavioral: Supervision
SAU consists of a 1-hour weekly group supervision session with the clinical team (typically 3-6 therapists). The on-site supervisor also conducts individual supervision sessions with each member of the clinical team. As such, the usual FFT supervision practice involves each therapist receiving two hours of supervision per week (one hour of group, one hour of individual). Supervision sessions are conducted by an on-site supervisor who has received intensive training in FFT supervision. The on-site supervisor also continues to receive feedback and guidance from a national consultant (FFT LLC) for one hour per month.
Other Name: SAU

Experimental: Observation Based Supervision
Behavioral: Observational Supervision
One intent of BOOST is to provide ongoing development of therapist clinical skills, and identify novel approaches to unique family circumstances that are consistent with FFT treatment. BOOST involves the BOOST supervisor reviewing the recorded therapy sessions prior to supervision sessions with the therapist and on-site FFT supervisor and weekly group and/or individual supervision meetings during which the BOOST supervisor provides feedback and coaching to the therapist. The goal of observation-based supervision is to ensure feedback to therapists is based on the supervisors' direct judgments about therapist behaviors, model adherence, and delivery of FFT services rather than relying solely on therapist self-report of session activities and interactions.
Other Name: BOOST

Primary Outcome Measures :
  1. Changes in Substance Use [ Time Frame: One Year ]
    Using V-Timeline Follow Back

Secondary Outcome Measures :
  1. Changes in Delinquency [ Time Frame: One Year ]
    Using Child Behavior Checklist and Youth Self Report

  2. Changes Family Functioning [ Time Frame: One Year ]
    Using Parent and Adolescent Report of Monitoring and Family Environment Scale

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  1. have at least one parent or parent figure (i.e., step-parent or surrogate) willing to participate;
  2. be 12 to 18 years of age (inclusive)
  3. be living at home with the participating parent
  4. have sufficient residential stability to permit probable contact at follow-up (e.g., not homeless at time of intake).

Exclusion Criteria:

  1. evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures
  2. has a sibling who is participating in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01614015

United States, Oregon
Oregon Research Institute
Eugene, Oregon, United States, 97403
Sponsors and Collaborators
Oregon Research Institute
Principal Investigator: Michael S. Robbins, Ph.D. Oregon Research Institute

Responsible Party: Oregon Research Institute Identifier: NCT01614015     History of Changes
Other Study ID Numbers: DA029406
First Posted: June 7, 2012    Key Record Dates
Last Update Posted: October 19, 2016
Last Verified: October 2016

Keywords provided by Oregon Research Institute:

Additional relevant MeSH terms:
Substance-Related Disorders
Self-Injurious Behavior
Chemically-Induced Disorders
Mental Disorders
Behavioral Symptoms